These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 7541613)

  • 1. Intratumor microvessel density as a prognostic factor in cancer.
    Weidner N
    Am J Pathol; 1995 Jul; 147(1):9-19. PubMed ID: 7541613
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor angiogenesis in advanced stage ovarian carcinoma.
    Hollingsworth HC; Kohn EC; Steinberg SM; Rothenberg ML; Merino MJ
    Am J Pathol; 1995 Jul; 147(1):33-41. PubMed ID: 7541612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis.
    Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R
    Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of the endothelial marker CD 34 in ovarian cancer.
    Heimburg S; Oehler MK; Papadopoulos T; Caffier H; Kristen P; Dietl J
    Anticancer Res; 1999; 19(4A):2527-9. PubMed ID: 10470188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
    Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
    Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
    Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
    Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of angiogenesis in epithelial ovarian carcinoma.
    Alvarez AA; Krigman HR; Whitaker RS; Dodge RK; Rodriguez GC
    Clin Cancer Res; 1999 Mar; 5(3):587-91. PubMed ID: 10100710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flt-4-positive endothelial cell density and its clinical significance in non-small cell lung cancer.
    Chen F; Takenaka K; Ogawa E; Yanagihara K; Otake Y; Wada H; Tanaka F
    Clin Cancer Res; 2004 Dec; 10(24):8548-53. PubMed ID: 15623638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary.
    Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Rollason TP
    Int J Gynecol Pathol; 2007 Oct; 26(4):395-403. PubMed ID: 17885489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?
    Jacobs TW; Siziopikou KP; Prioleau JE; Raza S; Baum JK; Hayes DF; Schnitt SJ
    Mod Pathol; 1998 Mar; 11(3):259-64. PubMed ID: 9521472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell adhesion in ovarian cancer.
    Elmasri WM; Casagrande G; Hoskins E; Kimm D; Kohn EC
    Cancer Treat Res; 2009; 149():297-318. PubMed ID: 19763442
    [No Abstract]   [Full Text] [Related]  

  • 12. Microvessel count: an indicator of poor outcome in medullary thyroid carcinoma but not in other types of thyroid carcinoma.
    Fontanini G; Vignati S; Pacini F; Pollina L; Basolo F
    Mod Pathol; 1996 Jun; 9(6):636-41. PubMed ID: 8782200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer.
    Chan JK; Magistris A; Loizzi V; Lin F; Rutgers J; Osann K; DiSaia PJ; Samoszuk M
    Gynecol Oncol; 2005 Oct; 99(1):20-5. PubMed ID: 16055178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma.
    Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR
    Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different pathways of macromolecule extravasation from hyperpermeable tumor vessels.
    Feng D; Nagy JA; Dvorak AM; Dvorak HF
    Microvasc Res; 2000 Jan; 59(1):24-37. PubMed ID: 10625568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer.
    Chan JK; Loizzi V; Magistris A; Lin F; Rutgers J; Osann K; Disaia PJ; Berman ML
    Clin Cancer Res; 2004 Dec; 10(24):8538-43. PubMed ID: 15623636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
    Weidner N; Carroll PR; Flax J; Blumenfeld W; Folkman J
    Am J Pathol; 1993 Aug; 143(2):401-9. PubMed ID: 7688183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival.
    Ali-Fehmi R; Morris RT; Bandyopadhyay S; Che M; Schimp V; Malone JM; Munkarah AR
    Am J Obstet Gynecol; 2005 Mar; 192(3):819-25. PubMed ID: 15746677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in primary and metastatic epithelial ovarian carcinoma.
    Abulafia O; Triest WE; Sherer DM
    Am J Obstet Gynecol; 1997 Sep; 177(3):541-7. PubMed ID: 9322621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.